Virendra Patel, MD
Vascular Surgery · New York, NYNPI 1265496962
Payments from drug & device makers
Across 343 payments — averaging $1719.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Shape Memory Medical Inc.$506K
- Cook Incorporated$23K
- Endologix LLC$14K
- Silk Road Medical, Inc.$9K
- Artivion, Inc.$7K
- Bolton Medical Inc$7K
- plus $22K from 27 others
Across 16 payments — averaging $1939.22 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Cook Research Incorporated$18K
- Shape Memory Medical Inc.$11K
- Artivion, Inc.$2K
What the payments were for
- Consulting fees$19,25029%
- Speaking & faculty fees$31,27547%
- Travel & lodging$3,8206%
- Food & beverage$12,18118%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Shape Memory Medical Inc. | 37 | $506,492 |
| Cook Incorporated | 11 | $23,425 |
| Endologix LLC | 9 | $13,947 |
| Silk Road Medical, Inc. | 3 | $9,226 |
| Artivion, Inc. | 8 | $7,199 |
| Bolton Medical Inc | 5 | $7,006 |
| Cook Medical LLC | 148 | $6,942 |
| Wilson Cook Medical Incorporated | 2 | $6,350 |
| Terumo Medical Corporation | 24 | $3,045 |
| W. L. Gore & Associates, Inc. | 28 | $2,292 |
| Boston Scientific | 8 | $798 |
| Abbott | 4 | $608 |
| Philips North America LLC | 4 | $470 |
| Musculoskeletal Transplant Foundation Inc. | 3 | $409 |
| Medtronic(2 entities) | 5 | $299 |
| Convatec Inc. | 7 | $161 |
| AbbVie(2 entities) | 7 | $152 |
| Integra Lifesciences Corporation | 5 | $140 |
| Johnson & Johnson(2 entities) | 6 | $126 |
| Cardiovascular Systems Inc. | 1 | $124 |
| Inari Medical, Inc. | 1 | $84 |
| Solventum Corporation | 3 | $67 |
| Angiodynamics, Inc. | 1 | $56 |
| Penumbra, Inc. | 4 | $46 |
| Kerecis Limited | 1 | $34 |
| Smith+Nephew | 1 | $29 |
| Misonix Inc | 1 | $28 |
| Argon Medical Devices, Inc. | 1 | $25 |
| Pfizer | 1 | $23 |
| Acell, Inc. | 1 | $22 |
| Lemaitre Vascular, Inc. | 1 | $19 |
| Tactile Systems Technology Inc | 1 | $15 |
| Cardinal Health 200 LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- IMPEDE EMBOLIZATION PLUG$13,098
- Cook Medical Zenith$9,262
- Cook Medical Thoracic$7,033
- Zenith Alpha$6,508
- Cook$6,386
- PhotoFix$5,600
- Zenith$2,677
- Cook Medical AAA$1,885
- GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis$1,410
- ANGIO-SEAL$800
- TR Band$700
- Navicross$663
- Jotec Products$500
- Zenith Spiral-Z$463
- Azur CX Detachable$424
- GLIDESHEATH SLENDER$413
- R2P MISAGO$413
- Zilver PTX$384
- EKOSONIC$363
- Diamondback Peripheral$322
How this compares
$589,673 in reported general payments places this provider in the 95th percentile of 405 vascular surgery providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 32 | $21,413 |
| XareltoRivaroxaban | 21 | $18,783 |
| SantylCollagenase Clostridium Hist. | 13 | $3,750 |
| ClopidogrelClopidogrel Bisulfate | 48 | $286 |
| Cilostazol | 16 | $270 |
| Oxycodone Hcl | 11 | $23 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $23 | $21,41332 claims |
| Johnson & JohnsonXarelto | $126 | $18,78321 claims |
| Smith+NephewSantyl | $29 | $3,75013 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 405 vascular surgery providers in New York.
Other vascular surgery in New York
- Gary GelbfishNew York$1.9M
- John LantisNew York$1.4M
- Brian DerubertisNew York$1M
- Thomas MaldonadoNew York$1M
- James McKinseyNew York$750K
- Peter FariesNew York$639K
- Rami TadrosNew York$351K
- Ajit RaoNew York$329K
- Todd BerlandNew York$328K
- Karan GargNew York$308K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.